Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Deciphering Antitumour Response and Resistance With INtratumour Heterogeneity (DARWIN II)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02314481
Recruitment Status : Recruiting
First Posted : December 11, 2014
Last Update Posted : February 1, 2019
Sponsor:
Collaborator:
Hoffmann-La Roche
Information provided by (Responsible Party):
University College, London

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : January 2023
Estimated Study Completion Date : January 2023